Team:Washington/Gram Negative/Build

From 2010.igem.org

(Difference between revisions)
(Building the Tse2/Tsi2 Toxin/ Antitoxin system)
(Using Recombineering to create a constitutive T6SS)
Line 26: Line 26:
<!---------------------------------------PAGE CONTENT GOES BELOW THIS---------------------------------------->
<!---------------------------------------PAGE CONTENT GOES BELOW THIS---------------------------------------->
-
=Using Recombineering to create a constitutive T6SS=
 
-
[[Image:Washington Recombineering.jpg|400px|thumb|right|Insertion of T7 promoters]]
 
-
The process for using homologous recombination to replace the T6SS native promoters is simple.  We begin with a previously characterised fosmid (a large, single-copy plasmid based on the F' plasmid) which contains all the genes in our T6SS.  Of particular interest is the ''fha1-tssA1'' intergenic region containing the promoters.  We transform this fosmid into recombineering strain ''E. coli'' SW102, which contains heat-inducible lambda phage recombinases and lacks the galactose metabolism gene ''galK''.
 
-
Using PCR, we create a cassette containing the ''galK'' gene flanked by 50 bp of homology to the intergenic region.  The lambda recombinases integrate the cassette into the fosmid.  The transformants are plated on minimal galactose media to select for the recombinants.
 
-
A second cassette is created via PCR, this time containing our new promoters.  In this case, we chose to use T7 phage promoters due to their constitutive expression and small size, making them easier to synthesize.  The promoters are again flanked with homologous regions, and integrated into the fosmid.  This cassette displaces the ''galK'' cassette.  The transformants are this time plated on 2-deoxy-galactose (DOG), which is a toxic homolog to galactose.  Cells which can metabolize galactose (that is, those with a functioning ''galK'' gene) are killed, while those without the gene are unharmed.
 
-
 
-
The final step is to transform the recombinant plasmid into a T7 polymerase expression strain, to allow T6SS constitutive expression.
 
=Building the Tse2/Tsi2 Toxin/ Antitoxin system=
=Building the Tse2/Tsi2 Toxin/ Antitoxin system=
[[Image:Washington_Building_Tse2_circuit.png|800px|]]
[[Image:Washington_Building_Tse2_circuit.png|800px|]]

Revision as of 23:46, 1 October 2010


Building the Tse2/Tsi2 Toxin/ Antitoxin system

Washington Building Tse2 circuit.png

Designing the Gram(-) Therapeutic       Testing the Gram(-) Therapeutic